Related Experiment Video
Updated: Oct 8, 2025

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
[Research and development technology platform and research progress of universal influenza vaccine]
T Deng1, J Y Zhang1, X M Yang2
1The 2nd Research Department of Viral Vaccine, Wuhan Institute of Biological Products, Wuhan Institute of Biological Products, Wuhan 430207, China National Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, China.
Abstract:
Vaccination is the most effective measure to prevent influenza. However, due to the existence of antigen drift and/or antigen shift of influenza virus, the vaccine strains often do not match the epidemic strains, so that the protection provided by influenza vaccine is still limited. With the rapid development of new vaccine technology, a kind of influenza vaccine with extensive protection or universal has attracted great attention. It can effectively induce humoral and cellular immunity against the conserved epitopes of influenza virus, provide good protection against various types/subtypes of influenza virus, and has a rapid production platform, which is the ideal goal for the development of a new generation of universal influenza vaccine. This article reviews the latest research progress of influenza universal vaccine.
More Related Videos
13:12Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
10:03Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013